The wellness platform’s results arrived amid heightened legal and regulatory scrutiny over its weight-loss-drug business.
Trending
- Standard Chartered to cut 15% of corporate functions roles by 2030
- How the Iran war is raising costs for AI chip companies
- LIRR Strike Jams Roads, Prompts Long Commutes as Talks Continue
- Spirit Airlines’ planes are heading to the desert, led by repo pilots
- OCC Issues Two Final Rules on Preemption of State Interest-on-Escrow Laws
- On-Chain: What You See Isn’t What It Means
- Top analysts suggest these 3 stocks for their long-term prospects
- Ryanair CFO warns weaker European carriers may not survive jet fuel crunch
Tuesday, May 19
